Philip H. Coelho, Director at Catalyst Pharmaceutical Partners, Inc. (CPRX), bought 8,000 shares at $0.67 ($5K) on 2010-02-26, disclosed to the SEC on 2010-03-03.
Open-market purchase of $5k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2021-08-26 | $264K | — | Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |